Seborrheic Keratosis Market Research Information: By Type (Reticulated, Stucco, Clonal, Dermatosis Papulosa Nigra, Others), Diagnosis (Skin Biopsy, Others), Treatment (Medication, Surgery, Laser Therapy), Distribution Channel - Global Forecast Till 2027
ID: MRFR/Pharma/4313-HCR | February 2021 | Region: Global | 100 Pages
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Seborrheic Keratosis Market, by Type
6.1 Introduction
6.2 Common Seborrheic Keratosis
6.2.1 Market Estimates & Forecast, 2020–2027
6.3 Reticulated Seborrheic Keratosis or Adenoid Seborrheic Keratosis
6.3.1 Market Estimates & Forecast, 2020–2027
6.4 Stucco Keratosis
6.4.1 Market Estimates & Forecast, 2020–2027
6.5 Clonal Seborrheic Keratosis
6.5.1 Market Estimates & Forecast, 2020–2027
6.6 Irritated Seborrheic Keratosis
6.6.1 Market Estimates & Forecast, 2020–2027
6.7 Seborrheic Keratosis with Squamous Atypia
6.7.1 Market Estimates & Forecast, 2020–2027
6.8 Melanoacanthoma
6.8.1 Market Estimates & Forecast, 2020–2027
6.9 Dermatosis Papulosa Nigra
6.9.1 Market Estimates & Forecast, 2020–2027
6.10 Inverted Follicular Keratosis
6.10.1 Market Estimates & Forecast, 2020–2027
Chapter 7. Global Seborrheic Keratosis Market, by Diagnosis
7.1 Introduction
7.2 Skin Biopsy
7.2.1 Market Estimates & Forecast, 2020–2027
7.3 Others
7.3.1 Market Estimates & Forecast, 2020–2027
Chapter 8. Global Seborrheic Keratosis Market, by treatment
8.1 Introduction
8.2 Medication
8.2.1 Market Estimates & Forecast, 2020–2027
8.3 Medical procedure
8.3.1 Market Estimates & Forecast, 2020–2027
8.4 Surgical Procedures
8.4.1 Market Estimates & Forecast, 2020–2027
8.5 Others
8.5.1 Market Estimates & Forecast, 2020–2027
Chapter 9. Global Seborrheic Keratosis Market, by Distribution Channel
9.1 Introduction
9.2 Hospital
9.2.1 Market Estimates & Forecast, 2020–2027
9.3 Clinics
9.3.2 Market Estimates & Forecast, 2020–2027
9.4 Pharmacies
9.4.1 Market Estimates & Forecast, 2020–2027
9.5 Diagnostic Centers
9.5.1 Market Estimates & Forecast, 2020–2027
9.6 Others
9.6.2 Market Estimates & Forecast, 2020–2027
Chapter 10. Global Seborrheic Keratosis Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K.
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Valeant
11.1.1 Company Overview
11.1.2 Types Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Allergan
11.2.1 Company Overview
11.2.2 Types Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Syneron Medical Ltd.
11.3.1 Company Overview
11.3.2 Types Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Aclaris Therapeutics
11.4.1 Company Overview
11.4.2 Types/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Cutera
11.5.1 Company Overview
11.5.2 Types Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 Lumenis
11.6.1 Company Overview
11.6.2 Types Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 BECTON DICKINSON AND COMPANY
11.7.1 Overview
11.7.2 Types Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Seborrheic Keratosis Industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Seborrheic Keratosis Industry Synopsis, 2020–2027
Table 2 Seborrheic Keratosis Market Estimates & Forecast, 2020–2027, (USD Million)
Table 3 Seborrheic Keratosis Market, by Region, 2020–2027, (USD Million)
Table 4 Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 5 Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 6 Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 7 Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 8 North America Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 9 North America Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 10 North America Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 11 North America Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 12 U.S. Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 13 U.S. Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 14 U.S. Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 15 U.S. Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 16 Canada Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 17 Canada Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 18 Canada Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 19 Canada Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 20 South America Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 21 South America Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 22 South America Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 23 South America Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 24 Europe Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 25 Europe Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 26 Europe Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 27 Europe Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 28 Western Europe Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 29 Western Europe Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 30 Western Europe Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 31 Western Europe Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 32 Eastern Europe Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 33 Eastern Europe Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 34 Eastern Europe Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 35 Eastern Europe Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 36 Asia Pacific Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 37 Asia Pacific Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 38 Asia Pacific Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 39 Asia Pacific Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
Table 40 Middle East & Africa Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)
Table 41 Middle East & Africa Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)
Table 42 Middle East & Africa Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)
Table 43 Middle East & Africa Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Seborrheic Keratosis Market
Figure 3 Segmentation Market Dynamics for Seborrheic Keratosis Market
Figure 4 Global Seborrheic Keratosis Market Share, by Type 2020
Figure 5 Global Seborrheic Keratosis Market Share, by Diagnosis 2020
Figure 6 Global Seborrheic Keratosis Market Share, by Treatment 2020
Figure 7 Global Seborrheic Keratosis Market Share, by Distribution Channel, 2020
Figure 8 Global Seborrheic Keratosis Market Share, by Region, 2020
Figure 9 North America Seborrheic Keratosis Market Share, by Country, 2020
Figure 10 Europe Seborrheic Keratosis Market Share, by Country, 2020
Figure 11 Asia Pacific Seborrheic Keratosis Market Share, by Country, 2020
Figure 12 Middle East & Africa Seborrheic Keratosis Market Share, by Country, 2020
Figure 13 Global Seborrheic Keratosis market: Company Share Analysis, 2020 (%)
Figure 14 Valeant: Key Financials
Figure 15 Valeant Segmental Revenue
Figure 16 Valeant: Geographical Revenue
Figure 17 Allergan: Key Financials
Figure 18 Allergan: Segmental Revenue
Figure 19 Allergan: Geographical Revenue
Figure 20 Syneron Medical Ltd.: Key Financials
Figure 21 Syneron Medical Ltd.: Segmental Revenue
Figure 22 Syneron Medical Ltd.: Geographical Revenue
Figure 23 Aclaris Therapeutics: Key Financials
Figure 24 Aclaris Therapeutics: Segmental Revenue
Figure 25 Aclaris Therapeutics: Geographical Revenue
Figure 26 Cutera: Key Financials
Figure 27 Cutera: Segmental Revenue
Figure 28 Cutera Geographical Revenue
Figure 29 Lumenis: Key Financials
Figure 30 Lumenis: Segmental Revenue
Figure 31 Lumenis: Geographical Revenue
Figure 32 BECTON DICKINSON AND COMPANY: Key Financials
Figure 33 BECTON DICKINSON AND COMPANY: Segmental Revenue
Figure 34 BECTON DICKINSON AND COMPANY: Geographical Revenue
Seborrheic Keratosis Market
Seborrheic Keratosis Market is expected to register a CAGR of 9.34% to reach USD 1,320.8 Million by 2027.
$1,320.8 Million
Market Size
9.34%
CAGR
North America
Dominating Region
2020-2027
Forecast Period
Segmentation
Key Players
- Aclaris Therapeutics
- Alma Lasers
- Angiodynamics
- Apira Science Inc.
- Becton Dickinson and Company
- Biolase Inc.
- BioLight Technologies LLC
- Coherent
Drivers
- Increasing government assistance
- rising prevalence of various skin lesions
Seborrheic Keratosis Market Scenario
Seborrheic keratosis is one of the common noncancerous skin growths in older adults. The growths mostly appear on shoulders, back, abdomen, face, chest, and scalp. Cryosurgery is the most preferred method to remove the growth. The method uses liquid nitrogen to freeze off the growth.
Notably, rising technological advancements and increasing participation of market leaders are the key factors driving the seborrheic keratosis market. For instance, in December 2017, Aclaris Therapeutics received FDA approval for Eskata (hydrogen peroxide). Eskata is a high-concentration hydrogen peroxide-based topical solution developed for the treatment of raised seborrheic keratoses.
Various other push factors such as growing demands for aesthetics, increasing government assistance, amendments in the regulatory framework, and rising funding and reimbursement continuously contributing to the growth of the seborrheic keratosis market. The increasing demands for aesthetics along with the rising prevalence of various skin lesions is making favorable backgrounds for the market to grow.
Despite these drivers, there are some issues associated with seborrheic keratosis market. Some of the challenges in the research and development, the high cost of treatment, side effects associated with surgical & other medical procedures, and poor healthcare system in low and middle-income countries may hinder the growth of the seborrheic keratosis market to an extent.
It is estimated that the seborrheic keratosis market is expected to grow at a CAGR 9.8% during the forecast period of 2017–2023.
Research Methodology
Sources: Annual reports, Press release, White paper, and Company presentation
Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Diagnostic Laboratories
- Government Research Institute
- Academic Institutes and Universities
Segmentation
The seborrheic keratosis market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of the type, the market is segmented into common seborrheic keratosis, reticulated seborrheic keratosis or adenoid seborrheic keratosis, stucco keratosis, clonal seborrheic keratosis, irritated seborrheic keratosis, seborrheic keratosis with squamous atypia, melanoacanthoma, dermatosis papulosa nigra, and inverted follicular keratosis. The common seborrheic keratosis is further segmented into basal cell papilloma and solid seborrheic keratosis. The stucco keratosis is further segmented into digitate seborrheic keratosis, hyperkeratotic seborrheic keratosis, serrated seborrheic keratosis, and verrucous seborrheic keratosis.
On the basis of the diagnosis, the market is classified into skin biopsy and others.
On the basis of the treatment, the market is classified as surgical procedures, medication, medical procedures, and others. The surgical procedures segment is further classified into cryosurgery, electrocautery or electrosurgery, curettage, and others. The medical procedures segment is further classified into freezing, tissue scraping, laser therapy, and others.
On the basis of the distribution channels, the market is segmented into hospital, clinics, diagnostic centers, pharmacies, and others.
Regional Analysis
The Americas dominate the Seborrheic keratosis market owing to the rising awareness among people about the condition and high healthcare expenditure. According to the statistical data suggested by Centers for Disease Control and Prevention (CDC), the total health expenditure in the United States was USD 3.2 trillion in 2015. Whereas, hospital care accounted for a share of 32.3%.
High prevalence of Seborrheic keratosis is also found to be a propelling factor in the Seborrheic keratosis market. According to a study published in Journal of Drugs in Dermatology in 2015, it is found that Seborrheic keratosis is one of the common cutaneous lesions which affects more than 83 million Americans. It is also reported that among all the patients with Seborrheic keratosis, around 33% have more than 15 Seborrheic keratosis lesions and 67% have 15 or fewer Seborrheic keratosis lesions.
Europe holds the second position in the Seborrheic keratosis market. It is expected that the financial support provided by the government, and private bodies for research & development and favorable reimbursement policies in the healthcare is likely to drive the Seborrheic keratosis market in the European region.
Owing to the huge patient pool, developing healthcare technology, and rising participation of market players, are driving the Seborrheic keratosis market in Asia Pacific. The Asia Pacific is the fastest growing Seborrheic keratosis market.
Increasing healthcare expenditure is also promoting the market growth in Asia Pacific countries. As per the statistics suggested by Australian Institute of Health and Welfare, it is found that the total healthcare expenditure was around USD 170.4 billion in 2015, i.e., 3.6% higher than the expenditure of 2014
The Middle East & Africa holds the lowest market share in Seborrheic keratosis market due to lack of technical knowledge and poor medical facilities.
Key Players
Some of key the players in the seborrheic keratosis market are Aclaris Therapeutics, Alma Lasers, Angiodynamics, Inc., Apira Science Inc., Becton Dickinson and Company, Biolase Inc., BioLight Technologies LLC, Coherent, Inc., Cutera, Erchonia Corporation, Integra Miltex, IRIDEX Corp., KAI Medical, Lumenis, Quanta Systems S.p.A., Quantumpm, Syneron Medical Ltd., Theralase Inc, THOR Photomedicine, Valeant, and others.
Frequently Asked Questions (FAQ) :
Seborrheic Keratosis is a noncancerous skin growth, mostly found in old adults.
Seborrheic Keratosis Market is expected to exhibit a strong 9.8% CAGR over the forecast period from 2020 to 2027.
Growing awareness about personal aesthetics is likely to be a key driver for the market.
Americas dominate the Global Seborrheic Keratosis Market.
Leading players in the Seborrheic Keratosis Market include Aclaris Therapeutics, Alma Lasers, and Cutera, among others.
